U.S. Wireless Telecom Stock News

Even if it's not a huge purchase, we think it was good to see that Gary Evans, the CEO & Chairman of United States...

With central banks signalling ongoing vigilance on inflation, hard assets are back in the spotlight and silver has attracted fresh attention. At the same time, demand from AI hardware, solar panels and electric vehicles is pulling more silver into industrial use. That gap between interest in inflation hedges and constrained mine investment is where opportunity sits. This article highlights three top silver stocks that are positioned for this theme. The stocks covered below are just a starting...

Why Alignment Healthcare Stock Is Back in Focus Alignment Healthcare (ALHC) is under fresh scrutiny after multiple shareholder rights law firms announced investigations into alleged accounting issues flagged by a whistleblower, including claims about misclassified expenses and inflated financial metrics. At a recent share price of US$13.62, Alignment Healthcare has seen short term momentum revive, with a 7 day share price return of 3.5% and a 90 day gain of 2.4%, although the 30 day share...

Fluor recently moved closer to completing Novelis’ approximately US$5.00 billion aluminum recycling plant in Bay Minette, Alabama, where it has been providing engineering, procurement and construction management services, with commissioning expected to begin before the end of 2026. This progress on a large, complex industrial project comes as valuation analyses suggest Fluor’s shares may be trading below estimates of their cash flow–based intrinsic value, potentially reshaping how investors...

Gap Inc. recently reported past second-quarter results showing net sales of US$3,651 million versus US$3,725 million a year earlier, with net income rising to US$501 million from US$216 million, alongside higher full-year earnings guidance and continued share repurchases under its 2026 buyback program. At the same time, Gap and DoorDash expanded on-demand access to Gap and Gap Factory merchandise across much of the U.S., and Gap appointed Michael Francis as incoming Old Navy CEO, moves that...

Conference appearance puts focus on Ligand Pharmaceuticals stock Ligand Pharmaceuticals (LGND) is set to present at the 17th Annual Midwest IDEAS Conference in Chicago on 26 August 2026 at 9:15 a.m., drawing attention to its business model and recent share performance. Recent trading has been slightly softer around the conference, with the share price down 1.42% over the past day and 2.45% over the past month. However, Ligand Pharmaceuticals still shows strong momentum with a 47.54% year to...

Global bond yields are rising as investors factor in the possibility of higher interest rates for longer. That shift keeps attention on sectors where government and long-cycle contracts can provide some visibility on revenue. For investors, the Aerospace And Defense screener helps focus on companies tied to that theme. This article highlights three stocks from the screener that may merit a closer look at this time. The three stocks below are only a starting sample. The full screen surfaced...

NewMarket (NEU) is back on investor radars after recent share price moves and a fresh look at its valuation profile. The stock closed at US$914.69, with an estimated intrinsic discount of 32.5%. Over the past few months NewMarket’s share price has gained momentum, with a 30 day share price return of 7.6% and a 90 day share price return of 14.7%. The 5 year total shareholder return of 193.4% highlights how strongly long term holders have been rewarded. Spot similar momentum stories by scanning...

Why a new class action lawsuit matters for GoDaddy investors GoDaddy (GDDY) is in focus after Kaplan Fox & Kilsheimer LLP filed a securities class action tied to the company’s 2025 promotions and subsequent bookings disclosures. For shareholders, the case raises questions about disclosure practices. Against this backdrop, GoDaddy’s 1 month share price return of 18.08% points to short term momentum building from the recent low base, even though the year to date share price return has declined...

Tempus AI (TEM) shares are drawing attention after the company received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, its AI software for detecting pulmonary hypertension from standard ECGs. The FDA news lands after a volatile stretch for Tempus AI, with the share price down 9.41% over the past day and 11.90% over the past week, yet still posting a 45.98% 30 day share price return and a 21.29% 90 day share price return. The 1 year total shareholder return is...

Earlier this week, Freedom Broker analysts issued a Sell recommendation on LGI Homes after new U.S. tariffs of up to 50% on more than 500 Canadian lumber and building material categories raised concerns about higher construction costs and margin pressure. The analysts warned that, with mortgage rates already constraining demand, LGI Homes may struggle to fully pass these cost increases to buyers, potentially forcing trade-offs between profitability and the pace of new community...

Blue Owl Capital (OWL) is back in focus after funds it manages led a US$2.4b compute equipment financing for IREN Limited, aimed at deploying NVIDIA Blackwell Ultra GPUs for AI Cloud expansion. Against this backdrop, Blue Owl Capital’s recent AI infrastructure financing arrives during a rebound in the stock. The 30 day share price return is 16.7% and the 90 day gain is 14.8%, even though the year to date share price return is down 21.49% and the 1 year total shareholder return is down 29.93%...

C.H. Robinson Worldwide recently reported past second-quarter 2026 results that beat earnings and revenue expectations, driven by stronger pricing and volume across key segments and improved operating profitability. An interesting takeaway is management’s continued confidence in achieving its 2026 adjusted operating income goals despite earlier downward estimate trends, underscoring operational discipline. Now we’ll explore how this earnings outperformance and management’s confidence could...

In August 2026, Guardant Health said it would appeal a US District Court of Delaware final judgment in a patent dispute with TwinStrand Biosciences and the University of Washington, with execution of the judgment and collection of potential royalties paused during the appeal. The court’s royalty order applies mainly to older Guardant tests, while Guardant reports that upgraded versions of key products such as Shield and Reveal, along with validated design changes to Guardant360, fall outside...

Takeda recently announced that the U.S. FDA approved MIMRYLO (rusfertide), a first-in-class hepcidin mimetic peptide, for treating erythrocytosis in adults with polycythemia vera, triggering US$275,000,000 in milestone payments to Protagonist Therapeutics. This approval not only validates Protagonist’s peptide platform but also establishes the first approved hepcidin mimetic therapy in polycythemia vera, potentially reshaping treatment approaches for hematocrit control and phlebotomy...

In its recently reported second-quarter 2026 results, Masco posted higher adjusted earnings that exceeded forecasts while net sales fell short and declined, and it lifted its 2026 adjusted earnings outlook driven largely by expected tariff refunds. Masco also returned US$454 million to shareholders through dividends and share repurchases during the quarter, underscoring its ongoing focus on capital returns even as sales softened. We’ll now explore how Masco’s higher adjusted earnings...

Cleveland-Cliffs (CLF) drew fresh attention after the U.S. Department of Energy set a framework to finalize a shared US$1b optimization project at its Middletown Works steel facility. The DOE backed project has arrived during a mixed period for Cleveland-Cliffs, with the share price falling about 14% year to date and over the past 90 days, yet still delivering an 8.1% total shareholder return over the past year. Investors appear to be weighing these longer term gains against more recent share...

DXP Enterprises (DXPE) is back on investors' radar after recent share price moves, with the stock last closing at $185.92. That price now reflects a market value of about $2.9 billion. While DXP Enterprises has pulled back in the last day and week, with the share price down 3.57% and 2.29% respectively, the stock still shows strong momentum with a 30 day share price return of 18.41% and a year to date share price return of 72.60%, alongside a three year total shareholder return above...

Recent performance snapshot for ITT stock ITT (ITT) has drawn fresh attention after recent price moves, with the stock closing at $202.99 on the latest trading day. Investors are weighing this against its past month and past 3 months total returns. That latest pullback of 2.39% in ITT’s share price over the day comes after a 7.09% 90 day share price return and a year to date share price return of 16.52%. The 1 year total shareholder return of 20.19% and 3 year total shareholder return of...

UL Solutions Inc. has recently expanded its Northern Italy site into a European Retail Center of Excellence and launched its Retail Total Access software platform, enhancing testing, regulatory, advisory and supply chain risk management services for retailers, brands and manufacturers across multiple product categories. Together, these retail-focused service and software expansions deepen UL Solutions’ role in helping customers manage product quality, compliance and supplier performance...

GitLab (GTLB) is back in focus after the company rolled out a wave of agentic AI and security product updates, including its Dedicated AI Gateway, Flow Creator Agent, and new Secrets Manager capabilities. Over the past year, GitLab’s share price performance has been mixed, with a 30 day share price return of 30.02% and a 90 day share price return of 32.79%, while the 1 year total shareholder return declined 6.56% and the 3 year total shareholder return declined 8.75%. This suggests that...

Domino's Pizza (DPZ) moved back into focus after shares rose 5.2% following a downgrade to Neutral, even as the stock trades near the US$350 level highlighted in that research. The 5.4% one-day share price gain comes after a mixed stretch for Domino's Pizza. The 90-day share price return of 11.6% contrasts with a year-to-date share price decline of 17.7% and a 1-year total shareholder return that has fallen 22.2%. Compare Domino's Pizza's recent swings with a hand picked group of resilient...

In June 2026, Iovance Biotherapeutics announced that the FDA allowed it to proceed with a Phase I/II basket trial of IOV-5001, a next-generation IL-12 tethered TIL therapy that uses a one-time regimen without IL-2 in multiple advanced solid tumors. This advancement highlights Iovance’s efforts to broaden its TIL platform beyond Amtagvi into high‑mortality solid cancers, potentially reshaping how its pipeline is viewed against other emerging TIL competitors. We’ll now examine how the FDA’s...

Antero Resources recently filed a motion with the Federal Energy Regulatory Commission to intervene in Columbia Gas Transmission’s Line KA4 Slip Repair Project proceeding in West Virginia, seeking a voice in how temporary construction workspaces near wetlands and streams are approved given its long-term transport contracts on the system. The company also reported second-quarter 2026 adjusted earnings and revenues that exceeded expectations, raised its full-year production guidance, and...